These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34853098)

  • 1. Validation of the predictive accuracy of health-state utility values based on the Lloyd model for metastatic or recurrent breast cancer in Japan.
    Iwatani T; Inoue E; Tsugawa K
    BMJ Open; 2021 Dec; 11(12):e046273. PubMed ID: 34853098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Health State Utility Values in Japanese Patients with End-Stage Breast Cancer.
    Iwatani T; Noto S; Tsugawa K
    Curr Oncol; 2021 Oct; 28(5):4203-4212. PubMed ID: 34677274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic literature review of health state utility values in head and neck cancer.
    Meregaglia M; Cairns J
    Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.
    Han R; François C; Toumi M
    Appl Health Econ Health Policy; 2021 Jan; 19(1):29-44. PubMed ID: 32661846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression.
    Wang Y; Gavan SP; Steinke D; Cheung KL; Chen LC
    Health Qual Life Outcomes; 2022 Dec; 20(1):169. PubMed ID: 36564800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN).
    Hawton A; Green C; Goodwin E; Harrower T
    Eur J Health Econ; 2019 Dec; 20(9):1335-1347. PubMed ID: 31410669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review.
    Paracha N; Thuresson PO; Moreno SG; MacGilchrist KS
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):549-559. PubMed ID: 27574879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring health state utility values of parents of children with a serious illness.
    Majmudar IK; Engel L; Muscara F; Stevenson C; McCarthy M; Anderson V; Mihalopoulos C
    Qual Life Res; 2020 Jul; 29(7):1947-1959. PubMed ID: 32335816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB).
    Xie F; Zoratti M; Chan K; Husereau D; Krahn M; Levine O; Clifford T; Schunemann H; Guyatt G
    Med Decis Making; 2019 May; 39(4):370-378. PubMed ID: 30902030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health state utility values by cancer stage: a systematic literature review.
    Pourrahmat MM; Kim A; Kansal AR; Hux M; Pushkarna D; Fazeli MS; Chung KC
    Eur J Health Econ; 2021 Nov; 22(8):1275-1288. PubMed ID: 34125315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses.
    Nerich V; Saing S; Gamper EM; Holzner B; Pivot X; Viney R; Kemmler G
    Breast Cancer Res Treat; 2017 Aug; 164(3):527-536. PubMed ID: 28497177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using health state utility values in models exploring the cost-effectiveness of health technologies.
    Ara R; Wailoo A
    Value Health; 2012; 15(6):971-4. PubMed ID: 22999149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.
    Ara R; Brazier J
    Med Care; 2012 May; 50(5):452-9. PubMed ID: 22002647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating Joint Health Condition Utility Values.
    Thompson AJ; Sutton M; Payne K
    Value Health; 2019 Apr; 22(4):482-490. PubMed ID: 30975400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review.
    Brockbank J; Krause T; Moss E; Pedersen AM; Mørup MF; Ahdesmäki O; Vaughan J; Brodtkorb TH
    Health Qual Life Outcomes; 2021 Mar; 19(1):94. PubMed ID: 33736649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden and health state utility values of eating disorders: results from a population-based survey.
    Le LK; Mihalopoulos C; Engel L; Touyz S; González-Chica DA; Stocks N; Hay P
    Psychol Med; 2021 Jan; 51(1):130-137. PubMed ID: 31670627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Mapping' Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases.
    Meregaglia M; Whittal A; Nicod E; Drummond M
    Pharmacoeconomics; 2020 Jun; 38(6):557-574. PubMed ID: 32152892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia.
    Cox IA; de Graaff B; Ahmed H; Campbell J; Otahal P; Corte TJ; Glaspole I; Moodley Y; Goh N; Macansh S; Walters EH; Palmer AJ
    Qual Life Res; 2021 Sep; 30(9):2615-2632. PubMed ID: 33999322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health state utility values among children and adolescents with disabilities: protocol for a systematic review.
    Kanya L; Anokye N; Ryan JM
    BMJ Open; 2018 Feb; 8(2):e019978. PubMed ID: 29467137
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.